NTRB

Nutriband Inc. develops transdermal pharmaceutical products, focusing on enhancing patient safety through its AVERSA™ abuse-deterrent technology. Its lead product is an abuse-deterrent fentanyl transdermal patch designed to provide extended-release chronic pain relief while preventing misuse and accidental exposure. The company aims to expand its portfolio by applying its technology to other pharmaceuticals with abuse potential, targeting global markets with patent protections in multiple countries. Nutriband operates in the healthcare sector, specifically within industrial specialties.